Nexalin Technology (NXL) EBITDA Margin (2022 - 2025)
Historic EBITDA Margin for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to 12550.4%.
- Nexalin Technology's EBITDA Margin fell 57546300.0% to 12550.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 5530.59%, marking a year-over-year decrease of 21028000.0%. This contributed to the annual value of 4508.8% for FY2024, which is 2780900.0% down from last year.
- Latest data reveals that Nexalin Technology reported EBITDA Margin of 12550.4% as of Q3 2025, which was down 57546300.0% from 2239.01% recorded in Q2 2025.
- Nexalin Technology's 5-year EBITDA Margin high stood at 24.83% for Q3 2022, and its period low was 12550.4% during Q3 2025.
- Its 4-year average for EBITDA Margin is 4209.73%, with a median of 2336.57% in 2023.
- Per our database at Business Quant, Nexalin Technology's EBITDA Margin crashed by -96358400bps in 2023 and then skyrocketed by 28649100bps in 2024.
- Quarter analysis of 4 years shows Nexalin Technology's EBITDA Margin stood at 1804.51% in 2022, then crashed by -111bps to 3807.33% in 2023, then tumbled by -174bps to 10425.19% in 2024, then fell by -20bps to 12550.4% in 2025.
- Its EBITDA Margin was 12550.4% in Q3 2025, compared to 2239.01% in Q2 2025 and 4845.81% in Q1 2025.